Panaxia and Neuraxpharm: First export of medical cannabis sublingual tablets to France
Ryan Allway January 24th, 2022 The first-of-its-kind export is part of the companies’ participation in the French government’s program to regulate the medical cannabis industry Both companies have previously issued their premium oils to patients in France DÜSSELDORF, Germany and TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ — Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX),... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )